Latest From Promega Corp.
The justices struck down an appeals court ruling that a single device component could count as a “substantial portion” under patent infringement laws.
The case between Promega and Life Tech turns on whether a company violates US patent law by shipping a single allegedly patented component overseas for assembly. The Solicitor General’s office says it does not, arguing that the Federal Circuit’s reading would expose US manufacturers to too much risk of patent liability.
Drug Discovery Tools
- Drug Discovery Tools
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Ophidian Pharmaceuticals Inc.
- North America
- Parent & Subsidiaries
- Promega Corp.
- Senior Management
William A Linton, Pres. & CEO
Dr. Randal Dimond, VP, Research
- Contact Info
Phone: (608) 274-4330
2800 Woods Hollow Rd.
Madison, WI 53711-5399
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.